1. Home
  2. ARI vs MLYS Comparison

ARI vs MLYS Comparison

Compare ARI & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARI
  • MLYS
  • Stock Information
  • Founded
  • ARI 2009
  • MLYS 2019
  • Country
  • ARI United States
  • MLYS United States
  • Employees
  • ARI N/A
  • MLYS N/A
  • Industry
  • ARI Real Estate Investment Trusts
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARI Real Estate
  • MLYS Health Care
  • Exchange
  • ARI Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • ARI 1.1B
  • MLYS 1.0B
  • IPO Year
  • ARI 2009
  • MLYS 2023
  • Fundamental
  • Price
  • ARI $9.72
  • MLYS $15.11
  • Analyst Decision
  • ARI Hold
  • MLYS Strong Buy
  • Analyst Count
  • ARI 5
  • MLYS 3
  • Target Price
  • ARI $9.50
  • MLYS $33.00
  • AVG Volume (30 Days)
  • ARI 1.3M
  • MLYS 710.0K
  • Earning Date
  • ARI 04-24-2025
  • MLYS 05-12-2025
  • Dividend Yield
  • ARI 10.28%
  • MLYS N/A
  • EPS Growth
  • ARI N/A
  • MLYS N/A
  • EPS
  • ARI N/A
  • MLYS N/A
  • Revenue
  • ARI $276,844,000.00
  • MLYS N/A
  • Revenue This Year
  • ARI $32.11
  • MLYS N/A
  • Revenue Next Year
  • ARI $19.41
  • MLYS N/A
  • P/E Ratio
  • ARI N/A
  • MLYS N/A
  • Revenue Growth
  • ARI 104.64
  • MLYS N/A
  • 52 Week Low
  • ARI $7.70
  • MLYS $8.24
  • 52 Week High
  • ARI $11.20
  • MLYS $18.38
  • Technical
  • Relative Strength Index (RSI)
  • ARI 60.07
  • MLYS 55.93
  • Support Level
  • ARI $9.30
  • MLYS $14.18
  • Resistance Level
  • ARI $10.00
  • MLYS $15.94
  • Average True Range (ATR)
  • ARI 0.19
  • MLYS 1.08
  • MACD
  • ARI 0.08
  • MLYS 0.05
  • Stochastic Oscillator
  • ARI 71.43
  • MLYS 72.70

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: